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Abstract
Sound statistical analyses are essential to the advancement of medicine. Although certainly
not always the case, far too many publications are based on weak or inappropriate statistical
methodology, leading to questionable results. Statistical reporting guidelines and standards for
research are being introduced which should help curb this problem. Wide recognition of the
need for statistical methodologies aligned with research questions and study designs, and the
impact when this is not the case, would help prevent this problem. In this thesis, I illustrate the
consequences of erroneous statistical analyses on data from an observational study on Multiple
Sclerosis and I investigate the impact of inappropriate survival analyses through a simulation
study.
Keywords: Survival analysis, p-value, statistical errors, model misspecification, interval
censoring
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Chapter 1
Introduction
High quality research is fundamental to the advancement of medicine but the quality of
medical research depends on the valid application, interpretation and reporting of statistics [84,
100, 115]. Poor quality research has serious ethical implications, as it can produce misleading
analysis and waste valuable resources [3, 4, 6, 12, 109]. The misuse of statistics has been
acknowledged in health-related literature since the first notable systematic review in 1966 [7,
70, 104]. Since then, many studies have reviewed the use of statistics, and subsequent statistical
reporting, in various areas of health-related research and have identified substantial errors [5,
7, 13, 15, 47, 63, 64, 70, 73, 75, 89, 90, 92, 97, 101, 107]. Notably, numerous reviews have
estimated the prevalence of such errors to be quite high, observing error rates of 38% or higher
[47, 63, 64, 89, 90, 92, 101, 119]. A Clinical trial is a special type of health-related study that
is strictly monitored and conducted by a large research team, often directly involving those
with statistical expertise. Therefore, the prevalence of errors in this research are much lower.
Guidelines have been developed and adjustments have been made to journal review processes
to help address the issue, particularly for other types of health-related studies [5, 7, 10, 11,
12, 22, 44, 46, 79, 83, 100, 118]. As a result, there have also been some improvements more
broadly [60]. However, despite the increased awareness and preventative measures, statistical
errors and poor reporting continue to be a real problem in health-related research [44, 100,
106, 109]. Furthermore, few guidelines exist that address the broad set of issues that arise
in analyses specific to observational studies [100]. In this chapter, I will describe the errors
in statistical analyses and statistical reporting that are commonly found in health and medical
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journal publications. Although statistical errors also exist in study design, this thesis only
investigates analytical errors.
1.1 Errors in Statistical Analysis
1.1.1 Inference Procedures
A common error that is discovered in systematic reviews of medical research is the application
of inappropriate statistical methods [13, 94, 101, 102]. Inappropriate tests are often applied
because researchers neglect to check if their data satisfy the test assumptions [57]. A consistent
mistake found through many published literature reviews is the violation of independence or
the failure to account for paired data [13, 69, 101, 123]. Another common mistake is the
inappropriate choice of parametric versus nonparametric statistical tests [39, 67, 69, 73, 101].
The Student’s t test, χ2 test and Analysis of Variance are three types of inference procedures
that are frequently applied even when test assumptions are violated [47].
Student’s t Test
Many medical research papers have incorrectly applied the Student’s t tests [63, 67, 89, 119].
These tests and assumptions are summarized in Table 1.1. The one-sample Student’s t test
is applied to quantitative data to evaluate the null hypothesis H0 : µ = µ0 against one of the
alternative hypotheses HA : µ , µ0, HA : µ > µ0 or HA : µ < µ0 [19]. The conditions for the
test are that the observations are independent, identically distributed and come from a normally
distributed population [19].
The independent samples t test is applied to quantitative data to compare two populations,
where µ1 and µ2 denote the respective population means [19]. The null hypothesis of the test
is usually H0 : µ1 − µ2 = 0 and is often evaluated against one of the alternative hypotheses
HA : µ1 − µ2 , 0, HA : µ1 − µ2 > 0 or HA : µ1 − µ2 < 0 [19]. The conditions for the
independent samples t test are that the samples are independent, the observations within the
samples are independent from each other, and they come from normally distributed populations
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[19]. There is a slightly different version of the independent samples t test, called the pooled
t test that imposes an additional strong assumption that σ1 = σ2 (i.e. it assumes the variances
are equal in both populations) [34]. The homogeneity of variances assumption for the pooled
Student’s t test is commonly violated in medical research [47, 119]. As well, violations of the
independent samples assumption have been regularly found in literature [67, 89, 101].
The sample means should follow a normal distribution in order to use the one- and two-
sample Student’s t tests, but most data used in medical research are not normally distributed
[47, 81, 86, 92]. Therefore, it is perhaps not surprising that violations of the normality assump-
tion are found often in systematic reviews of published medical papers [47, 64, 119].
The independent samples t test is not robust to violations of independence as correlations
among the errors severely bias test results [19, 29, 45]. In the presence of matched samples or
repeated measurements, the Wilcoxon Signed-Rank test is a nonparametric alternative to the
paired t test when normality is violated [34]. The independent samples t test can be fairly robust
against nonnormality and heteroscedasticity in a variety of situations [21]. However, when both
sample sizes and variances are unequal, the true type I error rate may deviate from the nomi-
nal significance level [21, 45]. Particularly, the t test is only robust against heteroscedasticity
when both populations are normally distributed, and when sample sizes are equal and greater
than 15 [48]. Therefore, there is concern regarding the application of parametric tests to ob-
servational data, where researchers have less control over sample sizes. Parametric tests are
also unreliable in the presence of outliers or heavy skewness [97]. When samples sizes are
small and distributions differ in both shape and skew, the sampling distribution of t statistics
will typically be skewed and result in biased type I error rates [21]. Nonnormality tends to
result in a loss of power [29]. It is of most importance that the condition of normality is sat-
isfied in the case of small sample sizes and such samples are used often in medical research
[87, 89, 92, 97, 101]. Therefore, assumption violations of the Student’s t test remain prob-
lematic, even after consideration of robustness. The Mann-Whitney U test is a nonparametric
alternative to the independent samples t test when normality is not satisfied, especially when
sample sizes are small [34, 67]. The Welch test is another alternative test when population
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variances are unequal [54].
Table 1.1: Comparison of Hypotheses and Assumptions of Student’s t Tests
One-sample Independent Samples
t test t test
H0 µ = µ0 µ1 − µ2 = µd0
HA µ , µ0, µ1 − µ2 , µd0 ,
µ > µ0, µ1 − µ2 > µd0 ,
µ < µ0 µ1 − µ2 < µd0
Assumptions independence, independence,
normality normality,
homogeneous variances
The erroneous technique of examining the overlap and widths of confidence intervals to test
for significant differences between groups has been applied in medical research [92]. Relative
to the standard method of hypothesis testing, the overlap method is deficient because it has
low, inconsistent power and is more conservative [103]. Based on the plot created by Schenker
and Gentleman (2001) [103], Figure 1.1 displays the asymptotic probabilities of Type I error
for the standard method versus the overlap method for the null hypothesis of no difference
between two population quantities. The plot illustrates how the probability for the overlap
method depends on the ratio of standard errors for the two populations and never reaches the
nominal significance level [103].
χ2 Test
Systematic reviews of medical literature have identified many papers that display incorrect
analyses of contingency tables and application of χ2 tests [63, 73, 97, 119]. The χ2 test of
independence is performed to evaluate evidence against the null hypotheses of independence
4
Figure 1.1: Asymptotic comparison of Type I error probabilities for the standard and overlap
methods of testing differences between two populations.
between two categorical variables [78]. The χ2 test can also be applied to multinomial data for
the goodness-of-fit test which evaluates evidence against the null hypothesis H0 : pi1 = pi2 =
· · · = pik, where pii is the probability of being in category i [34]. Independent observations and
large sample sizes are required for valid application of the χ2 test [78]. Specifically, the 20%
rule states that 80% of the expected cell frequencies in the contingency table should be at least
five and no expected cell frequency should be less than one [19]. However, the 20% rule is a
controversial one, as it is found by some researchers to be conservative [25, 38]. Nevertheless,
small expected cell frequencies can lead to poor chi-square approximations of multinomial
probabilities [25, 72].
The χ2 test is not robust to violations of independence, producing meaningless results when
both this condition is not satisfied and the P-value is small [19, 72]. However, the application
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of a χ2 test on paired data has been found in medical literature [58]. When the expected cell
counts in a 2 × 2 contingency table are too small, the χ2 approximation is unsound and Fisher’s
exact test may be applied instead. However, many authors fail to consider the impact of sample
size [13, 67, 105].
ANOVA
The one-way ANOVA is applied to multi-sample, quantitative data to assess the null hypoth-
esis H0 : µ1 = µ2 = · · · = µk against the alternative hypothesis that at least one population
mean differs from the others [19]. It is essentially an extension of the independent samples
pooled t test. The assumptions of ANOVA are that the samples are independent, normally dis-
tributed, simple random samples taken from k normally distributed populations with the same
variance [19]. Although the previously stated misuses of parametric versus nonparametric tests
involve misuses of ANOVA, specific errors concerning the application of ANOVA have also
been highlighted in medical research [13, 63, 64]. The ANOVA test is not robust against viola-
tions of independence and correlations among the errors severely bias test results [19, 29, 45].
Moreover, consequences of heteroscedasticity are more serious for ANOVA than for t tests
[48]. Inflated type I error rates are a consequence of heteroscedasticity, regardless of equality
of sample sizes [54]. It is not unusual for heteroscedasticity to exist in medical data; therefore,
violations of ANOVA assumptions are concerning [48]. The Brown and Forsythe F∗ test is
an alternative to one-way ANOVA when the assumption of homogeneous variances is violated
[48]. Similar to t tests, nonnormality will likely result in a loss of power in the ANOVA test,
especially in the case of extreme skewness [29, 45]. The Kruskal-Wallis Test is an alternative
test for comparing the means of k independent groups when the assumption of normality is
violated [34, 54].
P-values
In addition to a failure to satisfy test assumptions, another misuse of statistics in health and
medical research is the inappropriate use of tests to make multiple comparisons without con-
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trolling the overall type I error rate [13, 51, 63, 67, 92, 94, 101, 102]. Failure to adjust the
P-value when performing multiple applications of a statistical test inflates the overall probabil-
ity of making a type I error [59, 102]. Reviews of medical literature have discovered a variety
of errors surrounding the interpretation and calculation of P-values [63, 102].
One prevalent, interpretative issue includes the comparison of P-values from separate anal-
yses to evaluate differences between groups [7, 8, 63, 90]. Another prevalent error is the rigid
interpretation that P-values greater than 0.05 reveal similarities or no effect [18, 31, 39, 123].
The probability of the null hypothesis being true is also a common misinterpretation of the P-
value [66]. Discrepancies between reported test statistics and degrees of freedom have revealed
many P-value calculation errors in medical publications [43, 97]. Again, the actual frequency
of errors surrounding P-values may be underestimated in systematic reviews of medical litera-
ture because authors do not always report sufficient information to determine P-value accuracy
[94, 97].
The P-value is only an indicator of how unusual the observed test statistic is under a spe-
cific null hypothesis [16]. It was not originally intended to have the central, definitive and
objective position in decision making that it has in biomedical research [91, 93]. The depen-
dence on P-values has lead to the deceptive practice of P-hacking: the fishing for statistically
significant results throughout the research process [91]. However, if multiple tests are con-
ducted at a 5% level of significance, 5% of the P-values are expected to be no more than 5%
even when null hypotheses are true. Many of the “found” statistically significant results may
just be type I errors. As well, the definitive interpretation of P-values is problematic because
P-values are random variables that can be very different from sample to sample and are highly
dependent on sample size [49, 111]. Moreover, they are unstable and unreliable even when
study designs have considerable power [49]. The low test-retest reliability of P-values means
that they provide poor measures of evidence against the null hypotheses [49]. Alternatively,
researchers should use a variety of measures to assess evidence including graphical presenta-
tions and confidence intervals [49]. Bayes factors, such as the likelihood ratio statistic, offer
another alternative to P-values in inference [93]. The Bayesian approach treats unknown pa-
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rameters as random variables and the observed data as fixed [71]. In contrast to the frequentist
approach (i.e., P-values), the probability of the parameters given the data is determined [71].
The Bayesian approach might be preferred over the frequentist approach because it provides
straightforward and clear evaluation results [71].
Literature reviews have provided substantial evidence of the misuse of statistical inference
procedures. Moreover, these studies likely understate the actual prevalence of test misuse
because it is often the case that authors do not report enough information to allow readers to
validate the analyses performed [39, 63, 64, 92, 94, 101].
1.1.2 Quantifying Relationships between Variables
Correlation
The Spearman correlation coefficient is a more appropriate measure of correlation than the
Pearson correlation coefficient when variables have a nonlinear relationship, are not approxi-
mately normal or when data are ordinal [96]. However, the Pearson correlation coefficient is
commonly used in medical journals despite assumption violations [63, 64, 96].
Regression
Multivariate linear regression models assume a linear relationship between the response and
the associated predictor variables of the form Y |X = β0 + β1X1 + · · · + βpXp +  [2]. Along
with linearity, the regression model assumes that the n responses are independent, normally
distributed random variables with constant variance Var(Yi | X1, X2, ..., Xp) = σ2 and mean
E(Yi | X1, X2, ..., Xp) = µY |X = β0 + β1Xi1 + · · · + βpXip [2].
The logistic regression model also requires independent observations but assumes that the
outcomes are binary with a probability of success P(Yi = 1 | X1, X2, ..., Xp) = pi(X1, X2, ..., Xp)
[2]. As well, continuous predictors must have a linear relationship with their logit outcomes;
that is, logit
(
pi(X1, X2, ..., Xp)
)
= β0 + β1X1 + · · · + βpXp [108].
Errors in regression analyses that have occurred often in medical literature include over-
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fitting, violations of model assumptions, inappropriate evaluation of predictor variables and
improper choice between linear and logistic models [64, 67, 96, 101]. A major issue is that
medical researchers neglect clustering and fail to use hierarchical or mixed linear models when
appropriate [39]. As well, the flawed approach of using univariate analysis as a variable selec-
tion tool in multivariate models is a prevalent error in medical research [75, 101].
Missing data is another source of error in regression analysis, as inappropriate data han-
dling techniques can lead to biased parameter estimates and impact model conclusions [27]. A
systematic review of cancer prognostic studies established missing covariate data as a common
issue in multivariate survival analysis and found complete case analysis to be the most common
approach used by researchers [27].
Additionally, the modeling of time-to-event data is a source of error in medical research
[63]. The Cox model estimates multiplicative effects of predictors on the hazard function at
time t [56]. The main assumption of the Cox model is proportional hazards, which is the
condition that the ratio of hazard functions does not vary across time [56]. Time-dependent
bias, which results when time-dependent variables are treated as fixed variables in survival
analysis, was frequently found in leading clinical journals [116]. As well, analyzing time-to-
event data as fixed time observations, without accounting for censoring or differing follow-up
times, is a common issue [123]. A systematic review of research articles in clinical oncology
journals revealed an absence in reporting goodness of fit assessments and a lack of reporting
proportional hazards assessments for the Cox model [9].
1.1.3 Data Handling
The statistical error of using incorrect methods to analyze categorical versus quantitative data
has commonly been identified in medical research [67, 101]. Specifically, the application of
inappropriate analysis or descriptives statistics to ordinal data, such as the use of a parametric
test, has been observed in literature [13]. Another example of inappropriate analysis is the use
of a t test on categorical data [101].
The consequences of categorizing continuous data have been well documented and include
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power reduction, information loss and increased type I error rates [74, 99, 110, 117, 122].
Despite the established consequences, the technique of categorizing continuous variables is
still used frequently in medical research [8, 18, 36, 39, 75, 94, 95, 101].
Similar to the previous discussion concerning regression analysis, the inadequate handling
of missing data is a common issue for other analyses in medical research [18, 39, 51, 53]. Pop-
ular strategies include complete case analysis and single imputation methods; both strategies
are disadvantageous and lead to biased results [18, 39, 42, 51, 120].
1.2 Errors in Statistical Reporting
The reporting of statistical methods and results in medical research is another area subject to a
variety of errors [89, 92].
1.2.1 Omissions
Reproducibility is an important research objective [49]. The International Committee of Med-
ical Journal Editors recommends that authors of biomedical journal manuscripts report enough
detail regarding the statistical methods used to allow readers to confirm study results [35].
Yet, the omission of important information continues to be a widespread error in statistical
reporting [9, 14, 92, 97, 101]. A substantial problem in statistical reporting is the failure to
provide confirmation regarding the validation of assumptions for the statistical methods used
[14, 52]. Importantly, model diagnostics are also often omitted in reporting regression analysis
[14, 101]. As well, insufficient descriptions of methods used for analyses of survival data are
common in medical literature [9, 52].
Sensitivity analysis is recommended to assess the impact of missing data on study conclu-
sions, but is often not included in medical research [18, 51, 53, 120]. Similarly, power analyses
are largely omitted in medical literature and tend to only be used after a test fails to generate
statistically significant results [39, 41, 49, 52, 89, 92, 119]. In consideration of the important
research objective of reproducibility, power analysis is a valuable research tool that quantifies
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the reliability of the observed P-value in the context of study replication [49].
Although there is some evidence that statistical reporting of methodological details has
improved, the level and quality of reporting remains unsatisfactory [60].
1.2.2 Descriptive Statistics
Another statistical reporting issue in medical literature is the presentation of unsuitable numer-
ical summaries of data. The standard deviation is a preferred descriptive statistic for symmetric
data, otherwise, the range or interquartile range is preferred [87]. Conversely, the standard er-
ror of the mean is an estimate of precision in the sample mean and is an inappropriate descrip-
tion of the variability in a sample [88]. Nevertheless, unsuitable presentations of the standard
deviation and the standard error of the mean are detected frequently in medical publications
[13, 63, 88, 92, 94].
1.2.3 P-Values
Authors of medical research articles have demonstrated an undesirable reliance on P-values
to present test results [9, 18, 39, 63, 76, 97]. Valuable information regarding effect size and
precision are lost when authors report P-values alone without confidence intervals [76]. Au-
thors must report effect size to provide readers with a greater understanding of the strength and
relevance of study results, and to allow readers to draw their own study conclusions [31, 111].
The focus on P-values has diverted attention away from the practical importance of test results
[91]. Moreover, it is common for authors who report confidence intervals to do so in terms of
significance testing, rather than interpretation of data [41]. It is important to note that some
journals have taken action to address this issue. The journal of Epidemiology have discouraged
the presentation of P-values [68]. As well, the journal of Basic and Applied Social Psychology
has entirely banned the reporting of P-values [121].
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1.2.4 Graphical Summaries
Misleading, ambiguous and flawed graphs or figures are often sources of statistical errors in
medical journals [9, 32, 63, 96]. An example of a poor graph found in medical publications is
the summarization of correlation with the insertion of a regression line in a scatter plot [96]. As
illustrated in Figure 1.2, using a regression line to describe correlation can misguide readers
into deducing a strong linear relationship where one does not exist [96]. Erroneous graphs
of survival curves include unsuitable time scales, absences of distinguishing features between
multiple survival curves and displays of survival estimates inconsistent with text content [9].
Figure 1.2: The insertion of an irrelevant regression line through the scatter of points alludes
to the existence a linear relationship.
Although, errors occur mainly in basic statistical analysis, they are frequent, their con-
sequences can be serious and they result in published papers that draw faulty or misleading
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conclusions [8, 47, 70, 119]. Errors in the reporting of statistics can be equally damaging as
they cause readers to lose trust in the competence of the author [37].
1.3 Remainder of the Thesis
In the following chapters, I explore the application of erroneous statistical analyses on data
from an observational study on Multiple Sclerosis and investigate the impact of inappropriate
survival analyses through a simulation study. Contrasting the application of inappropriate and
appropriate analyses to the Multiple Sclerosis data in Chapter 2 will result in disagreement
between conclusions. Similarly, disparities among the performance of the misspecified models
will be observed in the simulation study in Chapter 3.
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Chapter 2
Analysis of Multiple Sclerosis Data
The review of literature has established the prevalence and seriousness of inappropriate sta-
tistical methodology in medical research. Now, I provide context and relevance to the issue.
In this chapter, I illustrate the consequences of erroneous statistical analysis on data from an
observational study on Multiple Sclerosis. The data for the application explored here were
extracted from the records of 54 patients at the London Health Sciences Centre Multiple Scle-
rosis Clinic in 2012 [80]. Multiple Sclerosis is an inflammatory disorder where neurological
episodes affect the brain and spinal cord [30]. Patients with Multiple Sclerosis experience
dysfunctions of their motor, sensory, visual, and autonomic systems [30]. Early diagnosis is
important because these symptoms may worsen over time and can result in tissue damage that
restricts the performance of daily activities [30]. Due to the importance of early detection of
MS, the medical sciences researcher was interested in using these data to study the factors
associated with delay time from onset of first symptoms to physician visit.
2.1 Contingency Tables
2.1.1 Example 1 - Analyses of Categorical Outcomes
The dataset contains information on the onset and trigger symptoms experienced by each pa-
tient. Onset symptoms are the first Multiple Sclerosis symptoms experienced by the patient,
whereas trigger symptoms are defined as the symptoms that lead the patient to seek medical
attention. The recorded onset and trigger symptoms were classified as either non-severe or
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severe.
Is there a change in severity between onset and trigger symptoms? To address this research
question, one may inappropriately construct the 2 × 2 contingency table displayed in Table
2.1. Then, applying the χ2 test of homogeneity with Yates’ continuity correction, H0 : pi1 = pi2
is evaluated against the alternative hypothesis HA : pi1 , pi2 and the computed test statistic is
χ2 = 14.14 with a P-value P < 0.001. Conforming with the unhealthy reliance on P-values in
published medical research, a conclusion of a statistically significant difference in severity is
made and the null hypothesis is rejected. However, the independence assumption of the χ2 test
Table 2.1: Inappropriate Contingency Table: Symptoms by Severity
Severity
Symptoms Non-Severe Severe Total by Symptom
Onset 26 28 54
Trigger 7 47 54
Total by Severity 33 75 108
is clearly violated because each observation contributes to two cells in the contingency table.
As a step in the right direction, the contingency table should be constructed as in Table 2.2,
where the total counts in the table equal the total sample size. Now, applying the χ2 Test to
Table 2.2 produces a test statistic of 0.84 with P = 0.36. The large P-value results in a failure
to reject H0. However, the application of the χ2 test is still problematic for two reasons. Further
calculations show that two expected cell frequencies are less than five. As well, the rows and
columns of the contingency table are still not independent since the variables represent repeated
measurements of severity at different stages of the disease for the same patient.
Alternatively, the McNemar test is the appropriate test to analyze these paired data in the
2 × 2 contingency table [58]. The McNemar test is similar to the χ2 test of homogeneity, but
the McNemar test evaluates evidence against the null hypothesis of equal proportions of sub-
jects within the contingency table’s discordant cells [58]. Discordant cells represent the pairs
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Table 2.2: Contingency Table: Severities of Onset and Trigger Symptoms
Trigger
Onset Non-Severe Severe Total
Non-Severe 5 21 26
Severe 2 26 28
Total 7 47 54
which have experienced a change in severity between onset and trigger symptoms and they
are identified as counts b and c in the contingency table in Figure 2.3 [58]. The test statis-
tic from the McNemar test statistic is χ2 = 14.09 with P < 0.001. Therefore, inconsistent
with the last χ2 test, the results of the McNemar test indicate that the sample provides suffi-
cient evidence to reject the claim that there is no change in severity between onset and trigger
symptoms. The results are summarized for comparison in Table 2.4. This scenario exemplifies
the inappropriate analysis of contingency tables that is commonly found in medical literature,
demonstrating how the failure to satisfy test assumptions leads to seemingly conflicting and
erroneous conclusions.
Table 2.3: Contingency Table: Severities of Onset and Trigger Symptoms
Trigger
Onset Non-Severe Severe
Non-Severe a b
Severe c d
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Table 2.4: Comparison of tests against the null hypothesis H0 : pi1 = pi2: Two inappropriate χ2
tests and the McNemar test.
Test χ2 P-value Conclusion
Test of Homogeneity on Table 2.1 14.14 < 0.001 Reject H0
Test of Homogeneity on Table 2.2 0.84 0.36 Fail to reject H0
McNemar Test on Table 2.2 14.09 < 0.001 Reject H0
2.2 Two Sample Inference
2.2.1 Example 2 - Inference on Population Means
The dates of onset symptoms and first clinical visits are also recorded in the dataset. Delay
time to clinical visit is defined as the difference in weeks between these two dates. The dataset
also records the clinical disease course of each patient: clinically isolated syndrome (CIS)
or relapsing-remitting multiple sclerosis (RRMS). CIS and RRMS are two different forms of
Multiple Sclerosis. A possible research question of interest may be the following: Is the mean
delay time for patients with RRMS equal to the mean delay time for those with CIS? It is im-
portant to note that some delay times are unknown, since the self-reported nature of the data
led to imprecise onset and first clinical visit dates. Since only completely observed records are
used to answer this question, results may be biased. The Student’s t test is repeatedly misused
in published medical research and could be incorrectly applied in this context. Investigating
the research question in the same manner, the independent samples t test is applied and the
test statistic is t = −1.735 with 23 degrees of freedom and P-value = 0.096. Imitating the
conclusive interpretations of P-values found in published medical research, CIS patients are
pronounced to not have delay times that are statistically different from RRMS patients. How-
ever, the presence of outliers and skew in Figure 2.1 show that the assumption of normality is
not satisfied.
Therefore, the nonparametric Mann-Whitney-Wilcoxon test should be applied to reason-
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Figure 2.1: Normal quantile-quantile plots and histograms for Multiple Sclerosis patients with
Clinically Isolated Syndrome (CIS) and those with Relapsing-Remitting Multiple Sclerosis
(RRMS).
ably address this research question. While the assumption of normality is not required for the
test, the populations must have equal spread. Table 2.5 displays measures of variability for
each group. Although the standard deviation and interquartile range for the two patient groups
show that the samples have quite different spread, these measures may be unreliable due to the
small sizes of the samples. Therefore, the nonparametric Fligner-Killeen test is used to assess
the equality of variances. The test obtains a large P-value equal to 0.63, showing a lack of
evidence against unequal variances.
Moving forward with the Mann-Whitney-Wilcoxon test generates test statistic, W = 129
with P-value = 0.77. Thus, much weaker evidence against the null hypothesis is obtained when
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Table 2.5: The standard deviation and interquartile range of delay times for patients with
Clinically Isolated Syndrome (CIS) and patients with Relapsing-Remitting Multiple Sclero-
sis (RRMS).
Sample Sample Size Standard Deviation (Weeks) Interquartile Range (Weeks)
(Complete Data Only)
CIS 11 6.54 6.45
RRMS 22 41.71 11.13
conducting the appropriate analysis.
I have demonstrated how ignoring the assumptions of a test produces adverse results in
both Example 1 and Example 2. Noting how often this occurs in published medical literature,
this consequence is troublesome.
2.3 Regression Analysis
2.3.1 Survival Models
Survival Analysis refers to the methods applied to analyze time-to-event data, where the re-
sponse variable is the time until an event of interest occurs [77]. Regression analyses may be
applied to model the relationship between survival time and one or more explanatory variables.
The essential characteristic of regression models for time-to-event data is that they take cen-
soring into consideration [82]. Censoring is the condition where the survival time is not known
exactly [82]. Observations may be right-, left- or interval-censored [77]. Right-censored obser-
vations exist when the event has not occurred before the last time point, left-censored observa-
tions exist when the event has already occurred before the first time point and interval-censored
observations exist when the event is known to have occurred between two time points [82].
Two common types of parametric regression models are the accelerated failure time (AFT)
regression model and the proportional hazards (PH) regression model.
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Accelerated Failure Time Regression Model
An accelerated failure time (AFT) regression model is of the form
log t j = x jβAFT + w j (2.1)
where t j represents survival time, x j is the vector of covariates, βAFT is the vector of coefficients
and w j is the random error term [82]. As displayed by Equation 2.1, the systematic effects in the
model are assumed to be additive on the natural logarithm of time. Additionally, the accelerated
failure time assumption assumes that
T1 = γT2 (2.2)
where T1 and T2 are random variables representing survival times for two groups, and γ is a
constant acceleration factor equal to exp (−βAFT) [65]. The distribution of the error term de-
cides the regression model [82]. Namely, if w follows the standard extreme value distribution,
extreme value distribution, normal distribution, or logistic distribution, then t has the expo-
nential distribution, Weibull distribution, log-normal distribution, or log-logistic distribution
respectively [82]. βAFTi is interpreted as the change in the logarithm of time associated with a
unit change in xi, holding all other covariates constant.
Proportional Hazards Regression Model
In proportional hazards (PH) regression, covariate effects are modeled to predict the hazard
ratio. The hazard rate is the instantaneous risk associated with the occurrence of an event [82].
The regression model is commonly of the form
h
(
t j
)
= h0
(
t j
)
exp
(
x jβPH
)
(2.3)
where the systematic effects are assumed to act multiplicatively on the baseline hazard func-
tion, h0(t). These models are referred to proportional hazards because it assumes the ratio of
hazards between two cases, hi (t) /h j (t), is fixed at a proportional amount. That is, propor-
tional differences in the hazard ratio are constant over time. βPHi is interpreted as the increase
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in the log hazard rate associated with a unit increase in xi, holding all other covariates con-
stant. However, some models may be expressed in either PH or AFT form. In fully parametric
models, the baseline hazard function is assumed to follow a specific distribution such as expo-
nential or Weibull [77]. When h0 (t) is unspecified, Equation 2.3 fits the semi-parametric Cox
proportional hazards model [82].
2.3.2 Example 3 - Analyses of Time-to-Event Data
Early treatment is considered to be advantageous in treating Multiple Sclerosis [40]. Notably,
delay time until first clinical visit has been found to be the greatest contributor to delay in
treatment [40]. Accordingly, a research question of interest may be: Which factors impact the
delay time of Multiple Sclerosis patients? As mentioned in Example 2, some delay times are
imprecise since the data are self-reported. These delay times are only known to be within an
interval of values. To address this research question, one may inadequately handle the presence
of interval censoring by imputing the intervals’ midpoint values, and then use multiple linear
regression to model delay time against covariates. The dataset includes variables describing
patients’ symptom severity, family history, fear or concern, presence of multiple symptoms or
infected areas, influence of daily activities, age and gender. Applying the automated selection
techniques of backwards elimination or forward selection, age of onset is found to be the only
statistically significant covariate. The results from the inappropriately fitted linear regression
model on the 54 patients are displayed in Table 2.6.
Table 2.6: Results from the inappropriately fitted linear regression model
Covariate Coefficient 95% Confidence Interval P-value
Age at Onset (Years) −8.70 (−13.36,−4.04) < 0.001
Intercept 328.18 (182.37, 473.98) < 0.001
Furthermore, residual-based diagnostics support inadequacies of the model. Figure 2.2
shows that the Normality assumption is not reasonable since the distribution of residuals appear
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heavily right skewed, due to the presence of outliers. As well, the residuals in Figure 2.3 are
not randomly scattered about zero and violate the constant variance assumption.
Figure 2.2: Normal quantile-quantile plot and histogram of residuals from the linear regression
of imputed delay time (midpoint) on Age at Onset for evaluation of the normality assumption.
Clearly this linear model poorly represents the data. To appropriately model this interval
censored, time-to-event data, survival analysis should be applied. As well, covariate selection
that is based solely on statistical significance may produce results that are not very useful [24].
Therefore, a combination of previous knowledge and stepwise regression are used to select
model covariates. It is well established that age and gender influence Multiple Sclerosis symp-
toms [20, 33, 50]. Accordingly, the effects of symptom severity, family history, patient fear
or concern, presence of multiple symptoms or infected areas, and influence of daily activities
are investigated after adjusting for age and gender. It is important to note that a small constant
has been added to each delay time to address the presence of times equal to zero. Weibull,
Exponential, Log-Normal and Log-Logistic AFT survival models are fit using the survreg()
function in the survival package, where the type of censoring for the Surv object is specified
as “interval2” [112, 113]. Only severity of onset symptoms is found to be a statistically sig-
nificant covariate. These results differ considerably from the previous linear regression model.
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Figure 2.3: Studentized residuals from the linear regression of imputed delay time (midpoint)
on Age at Onset plotted against Age of Onset and fitted values for evaluation of the constant
variance assumption.
Akaikes information criterion (AIC) and the log-likelihood are then used to compare the dif-
ferent parametric models. Table 2.7 displays the AIC statistics and log-likelihoods for the four
competing models. The Weibull model has the smallest AIC and the highest log-likelihood,
suggesting a better fit, relative to the other models.
Table 2.7: Akaike’s Information Criterion for the four competing models
Model AIC Log-Likelihood
Exponential 333.41 -162.70
Weibull 308.72 -149.36
Log-Normal 314.50 -150.59
Log-Logistic 311.17 -152.25
The results of the fitted Weibull regression model are displayed in Table 2.8.
The coefficient estimates are provided in AFT form. However, the Weibull regression
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Table 2.8: Results from the fitted Weibull accelerated failure time regression model
Covariate Coefficient βAFT 95% Confidence Interval P-value
Age at Onset (Years) −0.167 (−0.232,−0.101) < 0.001
Gender (Male) −0.172 (−1.293, 0.949) 0.76
Severity of Onset (Severe) −1.030 (−1.994,−0.066) 0.04
Intercept 8.631 (6.529, 10.732) < 0.001
Scale 1.70 (1.359, 2.123) < 0.001
model can be estimated in both AFT and PH form through the transformation
βPH = −βAFT ∗ a (2.4)
where a is the Weibull shape parameter [82]. The Weibull regression model also has the feature
that if the proportional hazards assumption holds, then the accelerated failure time assumption
holds, as well [65]. The proportional hazards assumption is assessed by examining plots of
the logarithm of the estimated cumulative hazard function against the logarithm of time. The
cumulative hazard function is estimated by using the Kaplan-Meier method to estimate survival
probabilities, Ŝ (t), and applying the formula log(− log Ŝ (t)) [24]. Figure 2.4 displays plots of
the logarithm of the cumulative hazard function against the logarithm of time for each covariate
in the model. Note that age of onset has been categorized into percentiles to facilitate the plot.
The assumption of proportional hazards is plausible if the plotted lines are parallel [24]. Since
the lines intersect in several areas, proportional hazards is clearly violated by the gender and
age covariates. Conversely, the lines for severity of onset appear reasonably parallel, except for
the earlier survival times. Furthermore, the lines in the plots should be approximately straight
if the assumed Weibull distribution is appropriate [65]. Although gender is questionable, the
plots in Figure 2.4 roughly support this assumption.
Next the accelerated failure time assumption is assessed by examining a quantile-quantile
plot of survival times. Figure 2.5 displays the quantile-quantile plot only for the severity of
onset covariate, since its survival estimation is of primary concern. A straight line through
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Figure 2.4: Logarithm of the cumulative hazard function for each group plotted against the
logarithm of time.
the origin with slope exp(̂β) has been added to the plot. If AFT is appropriate, the percentiles
should lie along this line [24]. The plot suggests the AFT is reasonable.
To further assess model adequacy, Figure 2.6 displays predicted survival curves by the
Weibull model along with the survival curves estimated by the Kaplan-Meier method for each
severity group. To facilitate prediction, age was fixed at its mean value and gender was set
to female. Although the probabilities are not very close, survival appears to be reasonably
estimated by the model. Results are similar for males.
Next, the deviance residuals for the model are examined in Figure 2.7. The residuals are
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Figure 2.5: Quantile-Quantile plot of survival distribution for patients with non-severe onset
symptoms against those with severe onset symptoms.
randomly scattered about zero and there are no concerning outlying points.
This example has made it evident that poor regression modeling and inadequate data han-
dling will produce a defective model, as is often the case in published medical literature. De-
spite the prevalence of these statistical errors, regression analyses are frequently applied in
medical research to make decisions. Hence, this is an issue with the potential to have serious
implications.
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Figure 2.6: Comparison of Kaplan-Meier estimates for survival probabilities with predicted
survival from the Weibull regression model
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Figure 2.7: Deviance residuals from the Weibull regression model plotted against the subject
identifier.
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Chapter 3
Simulation Study
3.1 Objective
The previous chapter illustrated how quite different conclusions can be reached depending
on whether or not appropriate analyses are used in the context of an MS application. The
review of medical literature has established that the inappropriate modeling of time-to-event
data, the inadequate handling of data and the severe reliance on P-values are all common
sources of error. Since P-values have highly trusted and central roles in published research,
it is important to investigate their behaviour. Therefore, in consideration of the prevalence of
errors, the objective of the simulation study is to assess the performance of P-values through the
application of inappropriate analyses on time-to-event data under different parameter settings.
3.2 Methods
3.2.1 Simulation Procedures
Two independent simulation studies were conducted using the statistical software R [98]. Each
study consisted of 5000 simulations. The studies each used a different data generation pro-
cedure, explored different parameter scenarios and applied distinct methods of inappropriate
modeling. For each simulated dataset, several statistical models were fit to allow for compari-
son of their performance across all of the 5000 simulated samples.
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3.2.2 Data Generation
Study A - Comparison of Models without Censoring
The goal of the first simulation study, Study A, was to investigate the performance of the P-
value for a hypothesis test associated with one covariate effect, subject to inappropriate model
fitting. Time-to-event data were randomly generated of the form
Y = log T =
1
a
W − log 1
b
− 1
a
βPHX′ (3.1)
where W follows a standard extreme value (type I) distribution and βPH denotes the coefficient
in proportional hazards form. That is, uncensored time-to-event data were generated under the
assumption of proportional hazards from a Weibull model with one covariate, as described by
the hazard function
h (t) =
a
b
( t
b
)a−1
exp
(
x′βPH
)
(3.2)
where the Weibull shape and scale parameters were a and b, respectively. The Weibull distri-
bution was selected for the simulation studies because it is highly versatile and is applied often
in survival analysis [23, 61]. The flexibility of the Weibull distribution is illustrated in Figure
3.1, where the scale parameter varies from 0.5 to 2.
The inverse transform method was used to generate w from the extreme value distribution
as recommended by Aaserud [1]. First, u was randomly sampled from the uniform distribution
over the interval [0,1]. Then, the inverse cumulative distribution function
F−1 (u) = − ln (− ln u) = w (3.3)
was applied to transform the values from the uniform distribution to those of the extreme value
distribution.
Study B - Comparison of Models with Censoring
The goal of the second simulation study, Study B, was to investigate the performance of the
P-value for a hypothesis test associated with a covariate effect, subject to the inadequate han-
dling of interval censored time-to-event data. As in Study A, Equation 3.1 was used to generate
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time-to-event data from a Weibull model with one covariate, under the assumption of propor-
tional hazards. Next, Study B incorporated interval censoring through two separate approaches.
The first approach implemented random, non-informative censoring and the second approach
implemented dependent, informative censoring, both of which are described below.
The random censoring mechanism began by determining which observations were com-
plete, s according to
si ∼ Bernoulli (1 − c) (3.4)
where c is the specified probability of obtaining a censored time. Then, the upper and lower
bounds for each interval censored time were constructed as
tai = ti − ai
tbi = ti + bi
where ai and bi are independent Exp (1) random variables. Thus, (tai , tbi) was the time input
for the response variable in the model. The exponential distribution with rate parameter λ = 1
was chosen to construct the intervals in order to generate intervals with widths that were similar
to the interval censored delay times in the Multiple Sclerosis dataset.
For informative censoring, the distribution of censoring was dependent on time to first
physician visit. It seems reasonable that the longer the delay time, the less precise the pa-
tient’s recollection of the timing of his/her first symptoms. The probability of censoring, ci was
determined for each ti generated by Equation 3.1 according to
ci =

0.2, if t < 24
0.4, if 24 ≤ t ≤ 48
0.6, if t > 48
where the cutoff points of 24 weeks and 48 weeks relate to the context of the Multiple Sclerosis
dataset. Particularly, it is reasonable to suppose that censoring rates would increase the farther
patients were from the date of their onset symptoms. Next, a censoring status was assigned to
each time by randomly sampling a number from Bernoulli (1 − ci) where a success represented
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an uncensored observation. As in the random censoring scenario, the interval bounds were
determined using observations of two independent Exp(1) random variables.
In the case where a censoring mechanism computed a non-positive lower bound for an
interval censored time, the lower bound was set equal to NA. This ensured valid time-to-event
data, but these cases represented a left censored survival event in the simulation.
3.2.3 Scenarios Investigated
The numerous scenarios investigated in the simulation study were motivated from the Multiple
Sclerosis dataset. In the studies, parameters values were varied as presented in Table 3.1 and
Table 3.2. A single covariate was considered in each module: a continuous one (i.e., X ∼
N(0, σ2)) and a discrete one (i.e., X ∼ Bin(1, p)). Next, I describe the parametric scenarios
explored in each study.
Study A - Comparison of Models without Censoring
The various parameters investigated in Study A are presented in Table 3.1. The time was
simulated to follow a Weibull distribution with a shape parameter that ranged from 0.5 to 2.0.
The four baseline Weibull hazard functions from which data were generated are displayed in
Figure 3.1. The range of shape values was chosen to achieve a variety of Weibull models
with monotone decreasing, constant and monotone decreasing hazards. As well, these shapes
were selected to include a shape similar to the parameter estimate obtained from the Multiple
Sclerosis data. Similarly, the decision to hold the Weibull scale parameter constant at b =100
was influenced by the high scale estimated in the Weibull model for the Multiple Sclerosis
data. The AFT coefficient for the covariate in the simulation ranges from −2 to 2. The values
for the coefficient were selected in order to allow exploration of a variety of cases that vary
from a model with no effect to a model with a relatively strong one. It is important to note
that in one covariate scenario, X was normally distributed with a centered mean and a standard
deviation of either 1 or 5. These standard deviations were chosen to include the standardized
case and a value similar to that of the continuous covariate in the fitted Weibull model for the
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Multiple Sclerosis data (i.e., age of onset). In the other covariate scenario, X is Bernoulli with
a a probability of 0.5 or 0.8. Lastly, the sample sizes of 50 and 250 were simulated to compare
a small sample size that was similar to the size of the Multiple Sclerosis dataset, to a relatively
large sample size. The probabilities for the binomial covariate were motivated by dichotomous
variables in the Multiple Sclerosis dataset (e.g., severity of onset symptom). A fully factorial
arrangement of the parameter values in Table 3.1 form the 416 scenarios considered in the
simulation.
Table 3.1: Parameters for the Weibull and covariate distributions investigated in Simulation
Study A
Parameter Values
Weibull Shape (a) 0.5, 1, 1.5, 2
Coefficient (βAFT) ±2, ±1.5, ±1, ±0.75, ±0.5, ±0.25, 0
Normal Covariate Scale (σ) 1, 5
Bernoulli Covariate Probability (p) 0.5, 0.8
Sample Size (n) 50, 250
Study B - Comparison of Models with Censoring
The various parameters investigated in Study B are presented in Table 3.2. Study B focused on
a subset of scenarios from Study A. The time was simulated to follow a Weibull distribution
with a shape of 0.5 and 2. These two shapes were chosen to target shapes which produced
considerably dissimilar results in Study A. The AFT coefficient for the model varied from −1
to 1, where the extreme values of the coefficient were omitted since they generally produced
uninteresting results in Study A. The standard deviation for the normally distributed covariate
was fixed at 1 because the standardized case produced the most diverse results in Study A. The
remaining parameters: Weibull scale, Bernoulli probability and sample size were held constant
at 100, 0.5 and 50, respectively. Additionally, the random censoring mechanism explored prob-
abilities of censoring equal to 0.2 and 0.4. The censoring probabilities were chosen to foster
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Figure 3.1: The four baseline Weibull hazard scenarios from which Study A generates data.
The scale is fixed at 100. The shape assumes the values 0.5, 1, 1.5 and 2.
the comparison of low and high censor levels. However, the small sample size of 50 made it
impractical to consider censoring probabilities closer to 1. Again, a fully factorial arrangement
of the parameter values in Table 3.2 form the 36 scenarios considered in the simulation.
3.2.4 Methods Evaluated
After time-to-event data were generated under each scenario, the studies apply various models
to estimate the coefficient for the covariate.
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Table 3.2: Parameters for the Weibull, covariate and censoring distribution investigated in
Simulation Study B
Parameter Values
Weibull Shape (a) 0.5, 2
Coefficient (βPH) ±1, ±0.75, ±0.5, ±0.25, 0
Random Censoring probability (c) 0.2, 0.4
Study A - Comparison of Models without Censoring
Study A used the survreg function in the survival package to fit Weibull, log-logistic, log-
normal and exponential parametric survival regression models on log transformed time, Y . As
well, coxph was used to fit a Cox proportional hazards regression model to the data, where
the Breslow method was used to handle tied event times. Furthermore, lm was used to fit two
simple linear regression models to the data; one on time and one on log transformed time.
Given the way the data were generated, the Weibull model was the correct model and the other
six models were considered inappropriate (i.e., were misspecified). The four inappropriate sur-
vival models were included because they represented the frequent error in medical literature
of fitting a model to data that violate assumptions. Similarly, the two simple linear regres-
sion models were fit to serve as typical applications of inappropriate methodology in medical
literature.
It is important to note that the Weibull and Cox model fitting procedures tracked failures to
converge within the simulation. In the rare occurrence of lack of convergence, the sample was
discarded and new data were generated to evaluate all methods.
Study B - Comparison of Models with Censoring
Study B used survreg to fit three Weibull survival regression models. The first Weibull model
classified the type of censoring for the survival object, Surv as “interval2”. Given the way the
data were generated, the first Weibull model was the correct model. Censoring was ignored
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in the second Weibull model where the midpoint of the time interval was used as the response
variable. In the third Weibull model, censored observations were completely disregarded; only
times when events were observed were included in the model. The latter two models were
evaluated because they represented inadequate approaches of handling incomplete data.
In the same manner as Study A, the three Weibull models were monitored for lack of
convergence.
3.2.5 Quantities Stored
The goal of both simulation studies was to assess the performance of inference on β by looking
at the results through P-values. Accordingly, the simulations stored the two-tailed P-value
associated with the estimated coefficient for the covariate in each model, based on the Wald test.
It is also possible to assess the performance of inference on β by inspecting the corresponding
confidence intervals. For that reason, each study stored the proportion of estimated confidence
intervals that fell entirely above (i.e., the lower limit was positive) or below 0 (i.e., the upper
limit was negative). The confidence intervals were constructed as
β̂ ± zα/2se(̂β) (3.5)
where α was set at 5%. This allowed evaluation of which methods incorrectly predicted the
direction of association between survival time and the covariate.
Where applicable, the number of datasets that experienced convergence failure during
model fit in each study were recorded to allow judgment of the methods’ reliability.
3.3 Results
The simulations have revealed some marked differences between the performances of the vari-
ous misspecified models. In this section, I describe the findings from Study A and Study B in
detail.
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3.3.1 Study A - Comparison of Models without Censoring
First, plots of the median P-values against β for each model were examined. Each model
was found to have a maximum median P-value at β = 0. This was anticipated since when
β = 0, the null hypothesis is true. One notable finding was that scenarios with the Bernoulli
covariate tended to produce more discernible differences between the models than scenarios
with the normal covariate. Figure 3.2 displays an example of this finding. Although, this is
for the specific scenario where the sample size was set at 50, similar results were observed
across other scenarios. This shows that inference on β for the discrete covariate was more
affected by inappropriate modeling than inference on β for the continuous covariate, based on
the results from this study. As well, the plot shows that the exponential model and the linear
model regressed on the logarithm of time tended to have higher P-values than the other models,
which indirectly motivate power and Type I error rate interpretations. Namely, higher median
P-values suggested a tendency to reject H0 less often. Conversely, the correct Weibull model
tended to have the lowest median P-values across various scenarios, suggesting higher power
and higher (i.e., closer to nominal) Type I error rate.
Another notable observation was that, apart from the scenario where Weibull shape = 1,
the exponential model consistently behaved very differently from all the other models. This
observation is seen in both of the plots in Figure 3.2. Additionally, Figure 3.3 illustrates this
result for the scenario with a Bernoulli covariate and Weibull shape of 0.5. In contrast with
Figure 3.2, the median P-values in Figure 3.3 are much lower for the exponential model than
for the other models.
The disparity detected between the models in the median P-value plots have exposed a
distinct pattern regarding the behaviour of the exponential model. Specifically, the behaviour
of the P-value for β in the exponential model was linked to the value of the Weibull shape
parameter. As seen in Figure 3.3, when the shape parameter was 0.5, the median P-values for
the exponential model fell below the medians associated with the other six models. Conversely,
Figure 3.4 shows that when the shape parameter was 1.5 or 2, the median P-value fell above
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Figure 3.2: Median P-values plotted against β values for each model under the scenarios of
Binomial and Normal covariates with sample size = 50.
those for the other models. When the shape parameter was equal to 1, the median P-values were
very similar to those of the other models. Figure 3.3 and 3.4 illustrate this pattern under specific
scenarios, but the result is consistent across other scenarios. It was clear that the behaviour of
the P-value for the exponential model fluctuated depending on Weibull’s shape, indicating that
the performance of a test of H0 : β = 0 is very sensitive to model misspecification involving
the use of exponential models when a Weibull should be used.
While the exponential model was noticeably different from the other models, the other
models also demonstrated apparent patterns in relation to each other. The median P-values
corresponding to the linear model regressed on the logarithm of time tended to perform very
closely to the log-normal survival model. This is a expected result since both models have
38
Figure 3.3: Median P-values plotted against β values for each model under the scenario of a
Binomial covariate with Weibull shape = 0.5.
the same response variable and impose an assumption of normality. As well, the linear model
regressed on time performed similarly to the log-logistic survival model. Likewise, the me-
dian P-values for the Weibull and Cox survival regression models performed similar to each
other. Since the Cox model did not impose a distributional assumption for the baseline hazard
function, its close performance to the correct Weibull model was sensible.
A more straightforward comparison of model performances occurred by examining the
proportions of P-values that were below the significance level, α = 0.05. Assessment of these
proportions against values of β for each model allowed direct, empirical estimations of Type
I error and power. The empirical Type I error rates were evaluated when β = 0 and power
estimates were evaluated when β , 0. Again, the performance of exponential model related to
the Weibull shape parameter. An instance of this is displayed in Figure 3.5, where the Weibull
shape parameter was 2. Aside from the drop in power experienced by the Cox model, the plot
shows that the exponential model obtains a lower Type I error rate and lower power, relative
to the other models. This tended to be the case when the Weibull shape parameter is 1.5 or
2. Conversely, when the Weibull shape parameter was 0.5, the exponential model obtained a
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Figure 3.4: Median P-values plotted against β values for each model under the scenarios:
Standard Normal covariate with Weibull shape = 1.5 and Binomial covariate with Weibull
shape = 2.
higher Type I error rate and higher power relative to the other models. The decrease in power
observed for the Cox model in Figure 3.5 may be due to the combined use of the Wald test to
assess the significance of a binary covariate and the Breslow method to handle tied event times
[62].
As well, the patterns displayed between the models with respect to their median P-values
were consistent with the patterns observed between the models with respect to their P-value
proportions. Apart from the erratic performance of the exponential model, the correct Weibull
model was found to consistently have the highest power across all scenarios. The linear model
regressed on the logarithm of time tended to have the lowest proportion of P-values less than α,
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until the values of |β| are greater than 0.75, where the linear model regressed on time then had
the lowest proportion. As well, the proportions corresponding to the linear model regressed on
time were found to be higher for negative coefficients and were not symmetric about β = 0,
especially in the case of the Bernoulli covariate. Consequently, both linear models conduct
inference on β with weak power, but the linear model regressed on time also demonstrated
inconsistent performance. Excluding the exponential model, the patterns among the models
and their relative order of performance did not change across the various values of the Weibull
shape parameter. However, the performances of the models did become more similar.
Figure 3.5: Proportion of P-values < 0.05 plotted against β for the scenario where Weibull
shape = 2.
Under the null hypothesis of β = 0, P-values should look like independent and identically
distributed uniform random variables [26]. Histograms were constructed to assess if simulation
results were consistent with this property. It was found that every model, except for exponen-
tial, roughly satisfied this uniformity condition. Hence, inference on β did not appear to be as
problematic in these inappropriate models. Figure 3.6 shows estimated densities for each model
under the null hypothesis where the sample size was 250 and the Weibull shape parameter was
1.5. The histogram corresponding to the exponential model in this case is asymmetric. Clearly,
testing the null hypothesis, H0 : β = 0 was not valid in the exponential model. Histogram find-
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ings were generally the same under the null hypothesis for other simulated scenarios; however,
the approximation to uniform was best when the sample size was large.
Figure 3.6: Histograms for each model under the scenario of a Normal covariate with β = 0,
sample size = 250 and Weibull shape = 1.5.
Consistent with results published in Murdoch et al. (2008) which explored the one-sample t
test for µ with Normal data, the distributions of P-values under the alternative hypothesis were
not uniformly distributed [85]. This result is shown in Figure 3.7 for the case of a small sample
size, a Weibull shape parameter 0.5 and β = 0.5. Findings were similar across other scenarios
but the distributions start to show increasing right skewness as |β| increases and as the Weibull
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Shape parameter increases. Another notable finding in Figure 3.7 is that the histogram for the
linear model on time is shaped differently than the others, as it appears almost bell-shaped with
less density for small P-values. This corresponds to the previous finding for this linear model,
where positive coefficients obtained lower power than negative coefficients.
Figure 3.7: Histograms for each model under the scenario of a Binomial covariate with β = 0.5,
sample size = 50 and Weibull shape = 0.5.
Next, inspection of the confidence intervals revealed that all methods produced a very small
proportion of intervals that incorrectly fell entirely above or below zero, but the exponential
model bore the largest proportion. Table 3.3 displays these results.
Lastly, only a small proportion of simulated datasets produced convergence failures. Specif-
ically, most of the convergence failures occurred for the Weibull model under the scenario of a
normal covariate and large values of |β|.
The differences that I have identified among the seven models in Study A are not substan-
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Table 3.3: Proportion of confidence intervals incorrectly entirely above or below zero, suggest-
ing the opposite direction of association, in Study A.
Model Proportion
Weibull 0.003
Linear on time 0.003
Linear on log(time) 0.002
Exponential 0.018
Log-Logisitc 0.003
Log-Normal 0.003
Cox 0.002
tial. That is, the misspecified models have performed reasonably similar to the correct Weibull
model. Specifically, they experienced a small reduction in power and a departure of the actual
Type I error rate from the nominal. Although the inappropriate models were expected to per-
form worse than they did, the results were not too surprising since completely observed data
were generated. Next, I describe the results from fitting misspecified models to data that were
not as well behaved.
3.3.2 Study B - Comparison of Models with Censoring
Random Censoring
There was more disparity between the inappropriate models applied in Study B than there was
between the models applied in Study A. Unlike Study A where the median P-values among
the models with the Normal covariate were almost indistinguishable (see Figure 3.2), results
were quite distinctive across the various scenarios in Study B. This suggests that inappropriate
modeling in the situation of censored data has a greater impact on the behaviour of P-values.
As well, the Weibull shape parameter continued to have a large impact on the distribution of
median P-values. Figure 3.8 illustrates these findings for the scenario of a normal covariate
44
and Weibull shape equal to 0.5. In this plot, median P-values are highest for the linear model
regressed on the logarithm of completely observed data and the linear model regressed on
untransformed, completely observed data. P-values were the lowest for the correct Weibull
model and the Weibull model applied to midpoint times. Again, median P-values motivate
power and Type I error rate interpretations, where lower median P-values suggested higher
power and Type I error rates.
Figure 3.8: Random censoring: Median P-values plotted against β for the case of a Normal
covariate and Weibull shape=0.5.
The influence of the Weibull shape parameter on the performance of P-values is explored in
Figure 3.9, where the proportions of P-values less than α are plotted against β for each model.
As anticipated from examining Figure 3.8, the correct Weibull model and the Weibull model
regressed on midpoint times performed very similarly and had the highest power relative to
the other models. Conversely, the two linear models which utilized only completely observed
times consistently had the lowest power. As well, it was found that the linear model regressed
on midpoint times, the linear model regressed on the logarithm of midpoint times and the
Weibull model regressed on completely observed times behaved similarly, but their relative
performance changed depending on the Weibull shape parameter. Specifically, the linear model
regressed on midpoint times tended to have the highest power of the three models when the
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Weibull shape parameter was 2.
In terms of Type I error, the Weibull model regressed on uncensored times typically had
the highest Type I error rate, whereas the linear models regressed on completely observed
times typically had the lowest Type I error rate. Findings were similar across other scenarios,
although power was generally higher for the case of the normal covariate.
Figure 3.9: Random censoring: Proportion of P-values < 0.05 plotted against β for the case of
a Binomial covariate and Weibull shapes equal to 0.5 and 2.
Next, Figure 3.10 shows the proportions of P-values less than α under the scenario of
the normal covariate, grouped by censoring probability. The separation between the model
performances was more apparent when the probability of censoring was higher, making the
patterns in performance that were observed in Figure 3.9 more distinct in Figure 3.10. It was
clear that the linear model regressed on complete data performed similarly to the linear model
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regressed on the logarithm of complete data. As well, the linear model regressed on midpoint
times, the linear model regressed on the logarithm of midpoint times, and the Weibull model
regressed on completely observed times obtained similar proportions. Lastly, the performances
of the correct Weibull model and the Weibull model regressed on midpoint times were very
much alike.
Figure 3.10: Random censoring: Proportion of P-values < 0.05 plotted against β for the case
of a Normal covariate and censoring probabilities equal to 0.2 and 0.4.
The distribution of P-values appeared approximately uniform under the null hypothesis,
with some exceptions. For the specific scenario of a Bernoulli covariate and a Weibull shape
parameter of 0.5 displayed in Figure 3.11, the linear model regressed on midpoint times and
the linear model regressed on completely observed times were not uniformly distributed. They
were asymmetrical with higher densities in the lower P-value range. Therefore, inference on
47
β was not valid in this case. Further examination of histograms have shown that the approxi-
mation to uniform under the null hypothesis improved for all models when the Weibull shape
parameter was 2. Additionally, the probability of censoring did not appear to have a substantial
effect on the distribution of P-values under the null or alternative hypothesis.
Figure 3.11: Random censoring: Histograms for each model under the scenario of a Binomial
covariate with β = 0 and Weibull shape=0.5.
Next, it was observed that the scenario with the Bernoulli covariate produced a higher
proportion of confidence intervals for β that incorrectly fell entirely above or below zero than
the scenario with the normal covariate. These results are displayed in Table 3.4.
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Lastly, it was found that only a negligible number of datasets resulted in convergence fail-
ures.
Table 3.4: Proportion of confidence intervals incorrectly entirely above or below zero, suggest-
ing the opposite direction of association, under random censoring in Study B.
Model Normal Proportion Binomial Proportion
Weibull 0.001 0.004
Weibull on complete 0.002 0.007
Weibull on midpoint 0.001 0.005
Linear on midpoint <0.001 0.003
Linear on log(midpoint) 0.001 0.005
Linear on complete 0.001 0.005
Linear on log(complete) 0.002 0.007
Informative Censoring
The main observation gained from the incorporation of informative censoring rather than ran-
dom censoring was that the performances of the various models differed from each other to a
greater extent. Figure 3.12 provides an example of this for the scenario of a normal covariate
and a Weibull shape of 0.5. The previously observed patterns were unmistakable in the pres-
ence of informative censoring. It is clear the the Weibull model regressed on midpoint times
continued to perform the closest to the correct Weibull model. It was also evident that the two
linear models that only utilized completely observed times consistently obtained the lowest
proportions of P-values less than α. Another important observation from Figure 3.12 is that
the correct Weibull model and the Weibull model regressed on midpoint times were the most
resistant to changes in the censoring mechanism, whereas the performances of the remaining
five models fluctuated with changes in censoring probability or changes in censoring type.
Relative to the Bernoulli covariate, the normal covariate tended to have higher power across
all values of β , 0. This was also a finding for random censoring, but it was more apparent
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in the case of informative censoring. As well, power tended to be higher when the shape was
equal to 2, rather than 0.5.
Regarding Type I error, the Weibull shape parameter of 0.5 produced greater variation in
the Type I error rates among the models than the Weibull shape parameter of 2. The three
Weibull survival models typically had higher Type I error rates than the four linear models.
These observed patterns were similar to what was found in the case of random censoring.
Notably, inference on β was valid for all models and both values of the Weibull shape
parameter, since the distributions of P-values appeared approximately uniform under the null
hypothesis.
Figure 3.12: Comparison of random and informative censoring: Proportion of P-values < 0.05
plotted against β for the case of a Normal covariate with Weibull shape=0.5.
As with random censoring, the scenario with the Bernoulli covariate produced a higher
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proportion of confidence intervals for β that incorrectly fell entirely above or below zero than
the case of the Normal covariate. These results are displayed in Table 3.5. As well, only a
negligible number of datasets resulted in convergence failures.
Table 3.5: Proportion of confidence intervals incorrectly entirely above or below zero, suggest-
ing the opposite direction of association, under informative censoring in Study B.
Model Normal Proportion Binomial Proportion
Weibull <0.001 0.004
Weibull on complete 0.002 0.011
Weibull on midpoint 0.001 0.006
Linear on midpoint 0.001 0.004
Linear on log(midpoint) 0.001 0.005
Linear on complete 0.002 0.005
Linear on log(complete) 0.003 0.008
3.4 Discussion
Based on the simulation studies, I conclude that the regression approaches investigation in
Study A are acceptable when the Weibull time-to-event data are not censored. That is, infer-
ences on β through simple linear regression t tests are reasonably adequate, but not as powerful
as the correct model. However, one must be cautious when inappropriately specifying an ex-
ponential model to Weibull data. Since the exponential model is a special case of the Weibull
model, I recommend applying the Weibull model instead.
In consideration of Study B, I conclude that inappropriate models and techniques for han-
dling censored, Weibull data are also acceptable, in some cases, as they result in valid tests
on β. However, the loss in power is large relative to the correct model. The loss of power
is an important consequence since authors experience strong incentives to publish statistically
significant results [55].
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An earlier study also investigated the application of simple linear regression analyses to the
midpoint of interval censored responses [114]. In contrast to the results in this simulation, the
earlier study found linear regression analyses to obtain reasonable power [114]. However, the
errors were simulated to follow a Gaussian distribution and little violation of the distributional
assumption were investigated.
3.5 Limitations and Future Directions
One surprising result was that the Weibull model regressed on midpoint values performed
very closely to the correct Weibull model. This may have occurred because the use of two
independent Exp(1) random variables to create the interval censored times may have resulted
in narrow intervals. I expect that differences between these two models would be more apparent
if the widths of the intervals were larger. Even though the presence of censoring demonstrated
an effect on the power of inference on β, perhaps the impact of censoring is more substantial
when the probability of censoring is larger. Since the level of censoring was limited by the
small sample size, a next strategy may be to simulate larger samples, with larger probabilities
of censoring. As well, it would be interesting to increase the degree of dependence within the
informative censoring mechanism to further study its impact on the performance of P-values.
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Chapter 4
Conclusion
I have provided an extensive review of the flawed use of statistics in published medical
research, showing that the existence of statistical errors in medical literature is widespread
and not new. Statistical errors are common within many areas of research and reporting. The
continued prevalence of the issue is concerning. Research informs the public, research informs
subsequent research and research informs medical practice [84, 115]. This transmission of
knowledge is damaged when research is published containing faulty or misleading conclusions,
since readers of medical journals are generally uncritical towards authors’ statistical analyses
[17]. Along with the impact on literature and the research process, there are significant ethical
implications and implications for science as a whole [3, 6].
I have investigated the impacts of the statistical errors identified in the literature review
through application of erroneous analyses to a dataset with medical relevance. The investiga-
tion effectively demonstrated that conflicting conclusions can be reached depending on whether
or not appropriate analyses are applied.
Furthermore, I have implemented a simulation study to investigate the impact of statistical
errors in the framework of regression modeling. Although, the results from the simulation
study have shown that inappropriate regression modeling may still be acceptable, tests on β
will suffer a considerable loss of power. This is a destructive consequence because researchers
face strong incentives to publish statistically significant results and a loss of power makes
significant results less attainable [55]. Moreover, low power can encourage deceptive practices
that lead to more statistical errors in published medical literature (e.g., P-hacking) [55].
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Steps have been taken to improve the use of statistics in journals. For example, an exper-
iment has shown that the inclusion of a statistical reviewer in the editorial process improves
the quality of manuscripts for the Medicina Clı´nica biomedical journal [28]. Not all articles
reviewed in Chapter 1 were recent and errors in published research may have changed over
time, but it was not the goal of this thesis to assess these changes. Although there have been
improvements in statistical practice, problems remain. Together, the consequences of statistical
errors and the transmission of knowledge aggravate the issue of erroneous statistical analyses
in published medical literature. A solution to this perpetuating problem may be found through
comprehension and recognition of its impact.
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